Samuel Ferret

703 total citations
7 papers, 181 citations indexed

About

Samuel Ferret is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Samuel Ferret has authored 7 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Virology and 3 papers in Emergency Medicine. Recurrent topics in Samuel Ferret's work include HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and HIV-related health complications and treatments (3 papers). Samuel Ferret is often cited by papers focused on HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and HIV-related health complications and treatments (3 papers). Samuel Ferret collaborates with scholars based in France, Australia and Ireland. Samuel Ferret's co-authors include Pierre de Truchis, Jean‐Michel Molina, Rishma Amarsy, Constance Delaugerre, Sébastien Gallien, Philippe Flandre, Dominique Mathez, Julie Timsit, Cecilia L. Moore and Waldo Belloso and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and AIDS.

In The Last Decade

Samuel Ferret

7 papers receiving 181 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Samuel Ferret France	6	109	104	51	40	25	7	181
Sharlaa Badal‐Faesen United States	9	161 1.5×	109 1.0×	71 1.4×	39 1.0×	30 1.2×	16	232
Win Min Han Thailand	9	132 1.2×	96 0.9×	90 1.8×	76 1.9×	22 0.9×	31	240
Mojgan Hessamfar France	9	115 1.1×	47 0.5×	89 1.7×	71 1.8×	10 0.4×	23	198
Sophie Farbos France	7	187 1.7×	157 1.5×	167 3.3×	35 0.9×	5 0.2×	12	259
Sirintip Sricharoenchai Thailand	8	70 0.6×	32 0.3×	60 1.2×	84 2.1×	6 0.2×	14	183
Anita Scribner United States	6	203 1.9×	156 1.5×	62 1.2×	48 1.2×	9 0.4×	7	245
Elisabetta Chiesa Italy	11	306 2.8×	242 2.3×	96 1.9×	63 1.6×	7 0.3×	17	351
Berend J. van Welzen Netherlands	9	136 1.2×	98 0.9×	75 1.5×	78 1.9×	3 0.1×	26	216
David Shamblaw United States	6	341 3.1×	239 2.3×	143 2.8×	48 1.2×	9 0.4×	7	379
G Moyle United Kingdom	7	158 1.4×	112 1.1×	56 1.1×	35 0.9×	2 0.1×	16	194

Countries citing papers authored by Samuel Ferret

Since Specialization

Citations

This map shows the geographic impact of Samuel Ferret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Ferret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Ferret more than expected).

Fields of papers citing papers by Samuel Ferret

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Ferret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Ferret. The network helps show where Samuel Ferret may publish in the future.

Co-authorship network of co-authors of Samuel Ferret

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Ferret. A scholar is included among the top collaborators of Samuel Ferret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Ferret. Samuel Ferret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Mercié, P., Caroline Roussillon, Christine Katlama, et al.. (2015). Varénicline versus placebo dans l’arrêt de la consommation de tabac au cours de l’infection par le VIH. Étude ANRS 144 inter-ACTIV. La Revue de Médecine Interne. 36. A26–A27. 2 indexed citations

Grabar, Sophie, Pierre Tattevin, Hana Selinger‐Leneman, et al.. (2015). Incidence of Herpes Zoster in HIV-Infected Adults in the Combined Antiretroviral Therapy Era: Results From the FHDH-ANRS CO4 Cohort. Clinical Infectious Diseases. 60(8). 1269–1277. 38 indexed citations

Haskelberg, Hila, Patrick Mallon, Jennifer Hoy, et al.. (2014). Bone Mineral Density Over 96 Weeks in Adults Failing First-Line Therapy Randomized to Raltegravir/Lopinavir/Ritonavir Compared With Standard Second-Line Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(2). 161–168. 12 indexed citations

Martin, Allison, Cecilia L. Moore, Patrick Mallon, et al.. (2013). HIV Lipodystrophy in Participants Randomised to Lopinavir/Ritonavir (LPV/r) +2–3 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) or LPV/r + Raltegravir as Second-Line Antiretroviral Therapy. PLoS ONE. 8(10). e77138–e77138. 14 indexed citations

Martin, Allison, Cecilia L. Moore, Patrick Mallon, et al.. (2013). Bone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapy. AIDS. 27(15). 2403–2411. 32 indexed citations

Bouldouyre, Marie‐Anne, Nathalie Verdière, Juliette Pavie, et al.. (2012). Quality of Travel Health Advice in a French Travel Medicine and Vaccine Center: A Prospective Observational Study. Journal of Travel Medicine. 19(2). 76–83. 11 indexed citations

Delaugerre, Constance, Sébastien Gallien, Philippe Flandre, et al.. (2012). Impact of Low-Level-Viremia on HIV-1 Drug-Resistance Evolution among Antiretroviral Treated-Patients. PLoS ONE. 7(5). e36673–e36673. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact